KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Accumulated Expenses (2017 - 2025)

Historic Accumulated Expenses for Staar Surgical (STAA) over the last 12 years, with Q3 2025 value amounting to $13.3 million.

  • Staar Surgical's Accumulated Expenses fell 528.97% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year decrease of 528.97%. This contributed to the annual value of $16.1 million for FY2024, which is 2892.4% up from last year.
  • Staar Surgical's Accumulated Expenses amounted to $13.3 million in Q3 2025, which was down 528.97% from $13.8 million recorded in Q2 2025.
  • Staar Surgical's Accumulated Expenses' 5-year high stood at $16.1 million during Q4 2024, with a 5-year trough of $5.1 million in Q2 2021.
  • Over the past 5 years, Staar Surgical's median Accumulated Expenses value was $11.1 million (recorded in 2021), while the average stood at $10.9 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 11517.14% in 2021, then tumbled by 1791.34% in 2022.
  • Staar Surgical's Accumulated Expenses (Quarter) stood at $12.0 million in 2021, then fell by 9.71% to $10.9 million in 2022, then grew by 15.26% to $12.5 million in 2023, then rose by 28.92% to $16.1 million in 2024, then decreased by 17.47% to $13.3 million in 2025.
  • Its Accumulated Expenses stands at $13.3 million for Q3 2025, versus $13.8 million for Q2 2025 and $11.0 million for Q1 2025.